Autologous peripheral hematopoietic stem cell transplantation （ABHSCT） for the treatment of leukemia patients

Six cases of acute leukemia patients were treated with ABHST and the clinical results were satisfactory. The preparation marrow ablative chemoradiotherpy regimen before ABHSCT was same to ABMT. The infusion number of mononuclear cell for restoring the hematopoietic function ran ged from 1.65 to 2.92×10⁸/kg. which contained 0.17 to 2.26×10⁴kg CFU-GM. The hematopoietic and immunological function of patients were recovered to normal level at 25 to 38 days after stem cells infusion, which was faster than ABMT and FLT. Two patients died of recurrence of leukemia. and fungi septicemia, 90 and 70 days after transplantation respectively, whereas the other four patients survived, free of leukemia up to 9,8,4,2 months respectively.